GW501516 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-12-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
| Property | Value | Notes |
|---|---|---|
| Chemical class | PPARδ agonist | Not an anabolic steroid. |
| Common synonyms | GW501516, GW-1516 | Cardarine is an informal name. |
| Appearance | White to off-white powder | Typical for research-grade solid. |
| Solubility class | Poorly soluble in water; soluble in some organic solvents | Such as DMSO or ethanol in laboratory settings. |
| Typical storage temperature | Cool, dry, protected from light | Specific conditions vary by supplier and form. |
It contained a "Mother's Room" in the tower for Eddy's personal use, furnished with rare books, silks, tapestries, rugs, a dressing gown and slippers, though she spent only one night there and it was later turned into a storage room. The archway into the room was made of Italian marble, and the word Mother was engraved on the floor. Within two years the Boston membership had exceeded the original church's capacity. By 1903 the block around the church had been purchased by Christian Scientists, and in 1906 the Mother Church Extension, accommodating 5,000 people, was completed at a cost of $2 million. This attracted the criticism that, whereas Christian Scientists spent money on a magnificent church, they maintained no hospitals, orphanages or missions in the slums. Christian Science went on to become the fastest-growing American religion in the early 20th century. The federal religious census recorded 85,717 Christian Scientists in 1906; 30 years later it was 268,915. In 1890 there were seven Christian Science churches in the United States, a figure that had risen to 1,104 by 1910. Churches began to appear in other countries too: 58 in England, 38 in Canada and 28 elsewhere by 1910.
Walthard cell rests, sometimes called Walthard cell nests, are a benign cluster of epithelial cells most commonly found in the connective tissue of the fallopian tubes, but also seen in the mesovarium, mesosalpinx and ovarian hilus.
When dealing in relative (gauge) pressures. For instance, an absolute pressure of 80 kPa may be described as a gauge pressure of −21 kPa (i.e., 21 kPa below an atmospheric pressure of 101 kPa). For example, abdominal decompression is an obstetric procedure during which negative gauge pressure is applied intermittently to a pregnant woman's abdomen. Negative absolute pressures are possible. They are effectively tension, and both bulk solids and bulk liquids can be put under negative absolute pressure by pulling on them. Microscopically, the molecules in solids and liquids have attractive interactions that overpower the thermal kinetic energy, so some tension can be sustained. Thermodynamically, however, a bulk material under negative pressure is in a metastable state, and it is especially fragile in the case of liquids where the negative pressure state is similar to superheating and is easily susceptible to cavitation. In certain situations, the cavitation can be avoided and negative pressures sustained indefinitely, for example, liquid mercury has been observed to sustain up to −425 atm in clean glass containers. Negative liquid pressures are thought to be involved in the ascent of sap in plants taller than 10 m (the atmospheric pressure head of water). The Casimir effect can create a small attractive force due to interactions with vacuum energy; this force is sometimes termed "vacuum pressure" (not to be confused with the negative gauge pressure of a vacuum).
Druze leaders: The Sheikh al-'Aql, Hikmat al-Hijri, called on Druze fighters to "resist this brutal campaign by all available means", the main sheikh of the Druze in Israel, Muwaffaq Tarif, declared, "The eyes and hearts of the Israeli Druze community are focused on the suffering of the Druze villages around Damascus", although he distanced himself from al-Hijri. Supreme Alawite Islamic Council: The Sheikh Ghazal Ghazal, the leader of the Supreme Alawite Islamic Council, pointed to the attacks against churches and members of the Druze community, emphasizing that "the perpetrator is the same, and the blood is the same". He stated that what the Alawite community has suffered has also affected other sects. Saraya Ansar al-Sunnah: The group threatened on 15 July to expand its sectarian attacks to include the Druze community in Suwayda. Islamic State: Abu Hudhayfa's group, affiliated with ISIS, declared that the Druze "violated the honor of Sunni Muslims," and that the goal of the attack was to kill the "infidel Druze". Minbar Ansar Al-Rasoul: The group celebrated the "victory" of the Internal Security Forces over the Druze protesters in Jaramana.
Sources: en.wikipedia.org
Elagolix, sold under the brand name Orilissa, is a gonadotropin-releasing hormone antagonist (GnRH antagonist) medication which is used in the treatment of pain associated with endometriosis in women. It is also under development for the treatment of uterine fibroids and heavy menstrual bleeding in women. The medication was under investigation for the treatment of prostate cancer and enlarged prostate in men as well, but development for these conditions was discontinued. Elagolix is taken by mouth once or twice per day. It can be taken for up to 6 to 24 months, depending on the dosage. Side effects of elagolix include menopausal-like symptoms such as hot flashes, night sweats, insomnia, amenorrhea, mood changes, anxiety, and decreased bone density, among others. Elagolix is a GnRH antagonist, or an antagonist of the gonadotropin-releasing hormone receptor (GnRHR), the biological target of the hypothalamic hormone gonadotropin-releasing hormone (GnRH). By blocking the GnRHR, it dose-dependently suppresses the gonadal production and hence circulating levels of sex hormones such as estradiol, progesterone, and testosterone. Elagolix is a short-acting GnRH antagonist, and can be used to achieve either partial or more substantial suppression of sex hormone levels. Reduced estrogen levels in the endometrium are responsible for the efficacy of elagolix in the treatment of endometriosis. Elagolix was first described in 2008 and was approved for medical use in July 2018.
=== Population === Like modern humans, Neanderthals probably descended from a very small population with an effective population—the number of individuals who can bear or father children—of 3,000 to 12,000 approximately. Neanderthals maintained this low population, proliferating weakly harmful genes due to the reduced effectivity of natural selection. Archaeological evidence suggests that the initial Cro-Magnon population was approximately 10 times higher than Neanderthals. Compared to Cro-Magnons, Neanderthals may have been at a demographic disadvantage due to a lower fertility rate, a higher infant mortality rate, or a combination of the two. In a sample of 206 Neanderthals, based on the abundance of young and mature adults in comparison to other age demographics, about 80% of them above the age of 20 died before reaching 40. This high mortality rate was probably due to their high-stress environment. Infant mortality was estimated to have been very high for Neanderthals, about 43% in northern Eurasia.
=== Shear-induced mixing === The strong static stability of a CAD inversion layer usually inhibits turbulent mixing, even in the presence of vertical wind shear. However, if the shear strengthens in addition to a weakening of the inversion, the cold dome becomes vulnerable to shear-induced mixing. Unlike solar heating, this CAD event erosion happens from the top down. Mixing occurs when the depth of the northeasterly flow becomes increasingly shallow and strong southerly flow makes a downward progression resulting in high shear.
Susan E. Leeman (May 9, 1930 – January 20, 2026) was an American endocrinologist who was renowned for her research on peptides. Leeman was a professor in the Department of Pharmacology and Experimental Therapeutics at Boston University. She continued to work into her nineties and later served as the director of the Neuropeptide Laboratory in the Pharmacology Department at the Chobanian and Avedisian School of Medicine. Her work with substance P and neurotensin, both of which are peptides crucial to the function of the nervous, endocrine, and immune systems, led to her becoming considered one of the pioneers of neuroendocrinology. Her later research focused on substance P specifically and how it binds with its receptor. Leeman was elected as a member within the National Academy of Sciences in 1991 and received the academy's Fred Conrad Koch Award in 1994. Leeman was a member of the Endocrine Society, Society for Neuroscience, American Association for the Advancement of Science, and American Physiological Society.
Selective estrogen receptor modulators (SERMs) are an important class of hormonal therapy agents which act as antagonists of the estrogen receptor and are used primarily for the treatment and chemoprevention of breast cancer. Some members of this family, such as tamoxifen, are actually partial agonists, which can actually increase estrogen receptor signalling in some tissues, such as the endometrium. Tamoxifen is currently first-line treatment for nearly all pre-menopausal women with hormone receptor-positive breast cancer. Raloxifene is another partial agonist SERM which does not seem to promote endometrial cancer, and is used primarily for chemoprevention of breast cancer in high-risk individuals, as well as to prevent osteoporosis. Toremifene and fulvestrant are SERMs with little or no agonist activity, and are used for treatment of metastatic breast cancer.
Sources: en.wikipedia.org
With the discovery of protactinium, most of the decay chains of uranium had been mapped. When Hahn returned to his work after the war, he looked back over his 1914 results, and considered some anomalies that had been dismissed or overlooked. He dissolved uranium salts in a hydrofluoric acid solution with tantalic acid. First the tantalum in the ore was precipitated, then the protactinium. In addition to the uranium X1 (thorium-234) and uranium X2 (protactinium-234), Hahn detected traces of a radioactive substance with a half-life of between 6 and 7 hours. There was one isotope known to have a half-life of 6.2 hours, mesothorium II (actinium-228). This was not in any probable decay chain, but it could have been contamination, as the KWIC had experimented with it. Hahn and Meitner demonstrated in 1919 that when actinium is treated with hydrofluoric acid, it remains in the insoluble residue. Since mesothorium II was an isotope of actinium, the substance was not mesothorium II; it was protactinium. Hahn was now confident enough he had found something that he named his new isotope "uranium Z". In February 1921, he published the first report on his discovery. Hahn determined that uranium Z had a half-life of around 6.7 hours (with a two per cent margin of error) and that when uranium X1 decayed, it became uranium X2 about 99.75 per cent of the time, and uranium Z around 0.25 per cent of the time.
Unallocated input satoshis in the transaction become the transaction fee. Losing a private key means losing access to the bitcoins, with no other proof of ownership accepted by the protocol. For instance, in 2013, a user lost ₿7,500, valued at US$7.5 million, by accidentally discarding a hard drive with the private key. It is estimated that around 20% of all bitcoins are lost. The private key must also be kept secret as its exposure, such as through a data breach, can lead to theft of the associated bitcoins. As of December 2017, approximately ₿980,000 had been stolen from cryptocurrency exchanges.
For services to the community in the area of Manningtree, Essex. Margaret Helena Booth. For political service. Patricia Mary Bottrill, Department Head (Ambulatory Care), Royal Victoria Infirmary, Newcastle-Upon-Tyne. For services to Health Care. Ruth Olive Boult. For services to the community in Messingham, South Humberside. Keith Du Brettargh Bowen. For services to disabled people in Leeds, West Yorkshire. Arthur Thomas Bowley. For services to the community in Brecon, Powys. The Reverend Father William Boyd, Officiating Chaplain, British Forces Rheindahlen. For services to the Armed Forces. John James Brady. For services to the Employment Service in Hebburn, Tyne and Wear. John Michael Brannon, Chairman, PMI Food Group UK, Foster Refrigerator Group of Companies. For services to Export. William Bratty. For charitable services to the community in Perth. Barbara Brewster, Personal Secretary, Board of Inland Revenue. Jean Brinkworth. For services to Guiding, particularly the Ranger Section, in the former South Glamorgan. Margaret Aline Jessica Brockbank. For services to the community in Bournemouth, Dorset. Wilfred Brockway. For services to the community in Fontmell Magna, Dorset. Cyril Albert Broom. For services to Legal Education. Barbara Brown. For political service. Jack Watson Brown. For political and public service. John Stuart Brown, General Medical Practitioner, Larkfield, Kent. For services to Medicine. Ronald Ezekiel Browne, Member, London Borough of Hammersmith and Fulham. For services to Local Government. Roger Ian Bryant.
=== Contaminants === Common chlorothalonil synthesis procedures frequently result in contamination of it with small amounts of hexachlorobenzene (HCB), which is toxic. US regulations limit HCB in commercial production to 0.05% of chlorothalonil. According to the EPA report, "post-application exposure to HCB from chlorothalonil is not expected to be a concern based on the low level of HCB in chlorothalonil. 2,3,7,8-Tetrachlorodibenzodioxin being one of the most potent carcinogens known is also a known contaminant".
== Afferent inputs == The PVN receives afferent inputs from many brain regions and different parts of the body, by hormonal control. Among these, inputs from neurons in structures adjacent to the anterior wall of the third ventricle (the "AV3V region") carry information about the electrolyte composition of the blood, and about circulating concentrations of such hormones as angiotensin and relaxin, to regulate the magnocellular neurons. Inputs from the brainstem (the nucleus of the solitary tract) and the ventrolateral medulla carry information from the heart and stomach. Inputs from the hippocampus to the CRH neurones are important regulators of stress responses. Inputs from neuropeptide Y-containing neurons in the arcuate nucleus coordinate metabolic regulation (via TRH secretion) with regulation of energy intake. Specifically, the projections from the arcuate nucleus seem to exert their effect on appetite via MC4R-expressing oxytocinergic cells of the PVN. Inputs from suprachiasmatic nucleus about levels of lighting (circadian rhythms). Inputs from glucose sensors within the brain stimulate release of vasopressin and corticotropin-releasing hormone from parvocellular neurosecretory cells.
Sources: en.wikipedia.org
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.
No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.
No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.